These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34832733)

  • 21. Challenges and strategies in developing microneedle patches for transdermal delivery of protein and peptide therapeutics.
    Wu F; Yang S; Yuan W; Jin T
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1292-8. PubMed ID: 22201589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing.
    Rajabi M; Roxhed N; Shafagh RZ; Haraldson T; Fischer AC; Wijngaart WV; Stemme G; Niklaus F
    PLoS One; 2016; 11(12):e0166330. PubMed ID: 27935976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.
    Al-Qallaf B; Das DB
    J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microneedle Technology: An Insight into Recent Advancements and Future Trends in Drug and Vaccine Delivery.
    Gupta J; Gupta R; Vanshita
    Assay Drug Dev Technol; 2021; 19(2):97-114. PubMed ID: 33297823
    [No Abstract]   [Full Text] [Related]  

  • 25. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine.
    Hong X; Wei L; Wu F; Wu Z; Chen L; Liu Z; Yuan W
    Drug Des Devel Ther; 2013; 7():945-52. PubMed ID: 24039404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanocomposite-strengthened dissolving microneedles for improved transdermal delivery to human skin.
    Yan L; Raphael AP; Zhu X; Wang B; Chen W; Tang T; Deng Y; Sant HJ; Zhu G; Choy KW; Gale BK; Prow TW; Chen X
    Adv Healthc Mater; 2014 Apr; 3(4):555-64. PubMed ID: 24173960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future of the transdermal drug delivery market--have we barely touched the surface?
    Watkinson AC; Kearney MC; Quinn HL; Courtenay AJ; Donnelly RF
    Expert Opin Drug Deliv; 2016; 13(4):523-32. PubMed ID: 26646399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved transdermal delivery of cetirizine hydrochloride using polymeric microneedles.
    Arshad MS; Hassan S; Hussain A; Abbas N; Kucuk I; Nazari K; Ali R; Ramzan S; Alqahtani A; Andriotis EG; Fatouros DG; Chang MW; Ahmad Z
    Daru; 2019 Dec; 27(2):673-681. PubMed ID: 31630328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
    Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
    J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal approaches to vaccinations in the COVID-19 pandemic era.
    Lee MS; Pan CX; Nambudiri VE
    Ther Adv Vaccines Immunother; 2021; 9():25151355211039073. PubMed ID: 34447901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microneedle integrated transdermal patch for fast onset and sustained delivery of lidocaine.
    Kochhar JS; Lim WX; Zou S; Foo WY; Pan J; Kang L
    Mol Pharm; 2013 Nov; 10(11):4272-80. PubMed ID: 24044683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Whole-Cell Inactivated
    Gala RP; Zaman RU; D'Souza MJ; Zughaier SM
    Vaccines (Basel); 2018 Sep; 6(3):. PubMed ID: 30181504
    [No Abstract]   [Full Text] [Related]  

  • 34. Dissolving Microneedle Patches for Dermal Vaccination.
    Leone M; Mönkäre J; Bouwstra JA; Kersten G
    Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microneedles for vaccine delivery: challenges and future perspectives.
    Shin CI; Jeong SD; Rejinold NS; Kim YC
    Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of microneedles and microchannels for enhanced transdermal drug delivery.
    Puri A; Nguyen HX; Tijani AO; Banga AK
    Ther Deliv; 2021 Jan; 12(1):77-103. PubMed ID: 33410340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
    Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
    Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microneedles and transdermal applications.
    Sivamani RK; Liepmann D; Maibach HI
    Expert Opin Drug Deliv; 2007 Jan; 4(1):19-25. PubMed ID: 17184159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microneedles for drug delivery: recent advances in materials and geometry for preclinical and clinical studies.
    Kang NW; Kim S; Lee JY; Kim KT; Choi Y; Oh Y; Kim J; Kim DD; Park JH
    Expert Opin Drug Deliv; 2021 Jul; 18(7):929-947. PubMed ID: 32975144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microneedles for drug and vaccine delivery.
    Kim YC; Park JH; Prausnitz MR
    Adv Drug Deliv Rev; 2012 Nov; 64(14):1547-68. PubMed ID: 22575858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.